SIRPA and cardiac arrhythmia: Furthermore, by robustly phenotyping input cell doses and correlating these with the resultant arrhythmia burden, we identify SIRPA+CD90+CD200+ and SIRPA+CD90−CD200− cells as populations of arrhythmogenic and potentially non-arrhythmogenic CMs, respectively.